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Abstract
Antiretroviral therapy to treat HIV/AIDS has substantially improved clinical outcomes among 
patients living with HIV/AIDS, but only in the presence of very consistent adherence. One of the 
most prevalent and impactful individual-level predictors of poor adherence is depressive 
symptoms, even at subthreshold levels. Evidence-based cognitive behavioral interventions exist to 
address improvements in depressive symptoms and adherence in this population, yet these 
techniques have largely been designed and tested as individual treatments for delivery in mental 
health settings. This presents a significant challenge when transporting these techniques to medical 
settings where other formats for delivery may be more appropriate (i.e., groups, less frequent 
visits) and few hands-on resources exist to guide this process. As such, primary aims of this study 
were to adapt and implement evidence-based cognitive behavioral techniques for depression 
(behavioral activation; BA) and HIV medication adherence (Life-Steps) that have potential for 
dissemination in an outpatient community health center. The intervention incorporated feedback 
from health center staff and utilized a modular, group format that did not rely on sequential 
session attendance. Feasibility was examined over 8 weeks (n = 13). Preliminary effects on 
depression, health-related quality of life, and medication adherence were examined and exit 
interviews were conducted with a subset of participants (n = 4) to inform future modifications. 
Treatment descriptions and recommendations for effective clinical implementation based on 
patient and clinician feedback are provided along with case material of two individual patients and 
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an example group session. Current efforts are an important next step for disseminating evidence-
based techniques for depression and HIV medication adherence to community health center or 
AIDS service organization settings.
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depression; HIV medication adherence; behavioral activation; CBT; community health center
Antiretroviral therapy to treat HIV/AIDS has substantially improved clinical outcomes 
among patients living with HIV/AIDS, but only in the presence of very consistent adherence 
(e.g., Crum et al., 2006). There are numerous barriers to achieving optimal levels of 
adherence; one of the most prevalent, impactful, and consistent individual-level predictors of 
poor adherence is depression (Gonzalez, Batchelder, Psaros, & Safren, 2011). Rates of 
depression among individuals living with HIV/AIDS are estimated to be approximately 42% 
(Horberg et al., 2008), and the presence of even subthreshold symptoms of depression has 
been shown to disrupt medication adherence; depressive symptoms have been associated 
with approximately a twofold increase in likelihood of poor adherence over time (Kacanek 
et al., 2010). Among HIV-infected substance-using individuals, even a 1-point increase in 
clinician-rated depressive symptoms on the Clinical Global Impression (CGI) severity scale 
(Guy, 1976) has been associated with a 75% increase in the odds of HIV medication 
nonadherence (Gonzalez et al., 2011); additionally, for each standard deviation increase on 
the Montgomery Asberg Depression Rating Scale (MADRS; Montgomery & Asberg, 1979), 
a 2.6-fold increased odds of nonadherence has been demonstrated. This has important 
implications for treatment outcomes, as medication nonadherence is associated with 
increased likelihood of producing medication-resistant HIV strains, greater health 
complications, failure to achieve full viral suppression (Bangsberg et al., 2001), and 
increased risk of death (de Olalla et al., 2002).
Evidence-based cognitive behavioral interventions have been developed to address 
improvements in both depression and HIV medication adherence among individuals living 
with HIV/AIDS with either clinical levels of depression or elevated depressive symptoms. 
Yet, it has been estimated that only 7% of HIV-infected individuals who require treatment 
for depression are receiving adequate treatment (Pence, O’Donnell, & Gaynes, 2012). These 
evidence-based techniques are rarely implemented in medical settings where many HIV-
infected individuals with the greatest treatment needs—such as low-income, minority 
individuals with psychiatric comorbidity—receive treatment (Altice, Kamarulzaman, 
Soriano, Schechter, & Friedland, 2010; Pence et al., 2012; Soller et al., 2011; Weaver et al., 
2008).
Specific to medication adherence, a brief, even single-session intervention, Life-Steps, is an 
evidence-based intervention that integrates informational, problem-solving, and cognitive 
behavioral components to improve HIV medication adherence (Safren, Otto, & Worthy, 
1999; Safren et al., 2001). Life-Steps has empirical support as a brief individual treatment 
across a range of settings, including outpatient behavioral health (Safren et al., 1999; 2001; 
2009), methadone maintenance (Safren et al., 2012), and international contexts (e.g., Cohen 
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et al., 2011; Shiu et al., 2012; Simoni et al., 2011). Although first developed as a single-
session intervention, recent adaptations (e.g., in international contexts) have delivered Life-
Steps across multiple sessions (Shiu et al., 2012; Simoni et al., 2011). When integrated with 
other treatments, the Life-Steps module is conducted initially in a single session and then 
reviewed in subsequent sessions to continue to identify barriers and strategies to improve 
adherence (Safren et al., 2009; 2012).
To address depression alongside improvements in adherence, evidence-based treatments for 
depression have been integrated with Life-Steps, including cognitive behavioral therapy 
(CBT) for depression (Safren et al., 2009; 2012) and behavioral activation (BA; Daughters, 
Magidson, Schuster, & Safren, 2010). BA holds particular promise when considering 
potential relevance for dissemination and flexible delivery of evidence-based techniques in 
HIV community health centers. BA is an evidence-based behavioral intervention based upon 
reinforcement theories of depression that targets increases in value-driven rewarding 
behaviors (Cuijpers, Van Straten, & Warmerdam, 2007; Lejuez, Hopko, Acierno, Daughters, 
& Pagoto, 2011; Lejuez, Hopko, LePage, Hopko, & McNeil, 2001; Mazzucchelli, Kane, & 
Rees, 2009; Sturmey, 2009). It is similar to the activity scheduling module of CBT 
(Jacobson et al., 1996), with a few key distinctions: BA includes an in-depth 
psychoeducation component on the relationship between depression and engaging in 
enjoyable and important behaviors. BA also includes behavioral monitoring with associated 
ratings of enjoyment and importance and a values-based assessment to guide activity 
selection.
Given its practical, straightforward nature, BA has been suggested to be particularly suitable 
for dissemination. Evidence suggests BA can be delivered as an individual or group 
approach and condensed into a briefer formats as practical barriers necessitate (e.g., 
Daughters et al., 2008; MacPherson et al., 2010; Magidson et al., 2011). It is also 
appropriate for training nonspecialized primary care providers (Ekers, Richards, McMillan, 
Bland, & Gilbody, 2011). These are characteristics that support its broad application across 
a range of clinical settings. Further, there is some evidence that more elaborate cognitive 
techniques may not be feasible or appropriate for individuals with low psychological insight, 
low education levels, chronic substance use histories, or cognitive impairment (Aharonovich 
et al., 2006; Aharonovich, Nunes, & Hasin, 2003). In addition to clinical depression, BA has 
been used to improve subthreshold depressive symptoms and distress regardless of 
depression diagnosis (Daughters et al., 2008; Magidson et al., 2011; Manos et al., 2009). BA 
also has been suggested to be easily tailored for medical and psychiatric comorbidities 
(Mazzucchelli et al., 2009; Sturmey, 2009) and has demonstrated positive effects on 
comorbid outcomes often independent of changes in depression (i.e., smoking, substance 
use; MacPherson et al., 2010; Magidson et al., 2011).
More specifically, BA has been adapted for low-income substance using and HIV-positive 
individuals; adaptations include emphasizing the link between activity, mood, and substance 
use, generating ideas for substance-free activities, incorporating relapse prevention into 
treatment (Daughters et al., 2008; Magidson et al., 2011), and identifying links between 
activities and poor HIV medication adherence (Daughters et al., 2010). These modified BA 
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techniques have been previously integrated with Life-Steps in a 16-session, manualized 
individual treatment format (Daughters et al., 2010).
Despite the potential for dissemination of BA to improve depression across a range of 
settings and empirical support for delivery of BA in groups (e.g., Daughters et al., 2008; 
Magidson et al., 2011; Porter, Spates, & Smitham, 2004) and in primary care specifically 
(Ekers et al., 2011), BA and Life-Steps have largely been delivered as individual treatments 
in mental health settings. This presents a significant challenge when transporting these 
techniques to medical settings, where many individuals with the greatest need for treatment
—such as low-income, minority HIV-infected individuals with psychiatric comorbidity—
seek care (Soller et al., 2011). Few resources exist to guide how to adapt these interventions 
and techniques for a medical setting and, in particular, into a group format, which may be 
the most feasible and cost-effective option for low-resource community health settings. 
Further, other features of a mental health setting, such as trained mental health providers, 
sequential, weekly treatment attendance, and a unified presenting problem may not be 
realistic in medical settings. Implementing interventions in a medical setting that were tested 
and designed for individual treatment in a mental health setting is a struggle across types of 
disorders and interventions, particularly for low-resource settings such as HIV community 
health centers that commonly treat individuals with multiple psychiatric and medical 
comorbidities (Altice et al., 2010; Soller et al., 2011).
As such, the primary aim of the current study was to adapt evidence-based BA treatment 
techniques for depression and Life-Steps for HIV medication adherence for low-income, 
minority patients infected with HIV who were receiving care at an outpatient community 
health center. This treatment center had not implemented evidence-based CBT techniques 
prior to this project. In this report, the resulting “Act Healthy” group treatment is described 
in more depth, including the specific modifications and adaptations for implementation in a 
community health center. Case material of two individual patients and an example group 
session are depicted to portray this approach with greater clarity. Feedback from individual 
exit interviews is presented, along with recommendations for effective clinical 
implementation based on clinician and patient feedback. Effects on depressive symptoms, 
medication adherence, and mental and physical health-related functioning over 8 weeks are 
briefly discussed. If evidence-based interventions for adherence and depression can be 
integrated into real-world outpatient medical settings where patients typically receive 
regular, ongoing care, this has important clinical implications for both treatment and 




The current study was conducted at an urban outpatient community health center that 
specializes in HIV/AIDS and LGBT health care and also provides primary health-care 
services for the community regardless of HIV status, sexual orientation, or gender identity. 
Center services include primary medical care, HIV/AIDS primary care, dental care, medical 
adherence, legal help, pharmacy services, behavioral health, and a computer for patient 
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access. For patients with severe mental health needs, daily treatment groups are offered, 
which are typically delivered by a licensed clinical social worker (LCSW) and focus on 
topics such as addictive behaviors, aging with HIV/AIDS, and spirituality. Given few 
evidence-based cognitive and behavioral techniques being utilized in the center to address 
psychiatric comorbidity, most commonly depression, the Act Healthy group was 
implemented and evaluated for use at this center.
Specific Adaptations for This Format and Setting
Prior to implementing the group, we met with core treatment staff (center director, head 
registered nurse, and LCSW) to understand primary treatment needs, center structure, and 
patterns of attendance. The primary difference that emerged in comparison to traditional 
mental health settings was the less frequent, irregular attendance (i.e., as opposed to regular 
weekly or biweekly treatment sessions). In comparison, patients were not attending weekly 
or on consistent days, and thus we could not rely on sequential weekly treatment structure 
often implemented in an outpatient mental health setting. Another key theme that emerged 
was the reliance on a group format. Given the high patient caseloads and staff burden, 
particularly for dedicated behavioral health staff, the majority of treatment was delivered in 
groups. Thus, the key challenge was how to design a structure that would utilize the 
evidence-based techniques effectively in a group using a format that would be effective for 
both patients who had attended the previous week(s) alongside those who had not been 
present. Given this challenge, we aimed to design an evidence-based curriculum that would 
build upon previous content but also provide a sufficient overview and review for members 
who had not attended previously.
Another key issue presented by center staff was the preference to include all interested 
patients, regardless of psychiatric diagnosis. In line with this suggestion, we chose to not 
have specific inclusion criteria for the group or study, which seemed clinically appropriate 
given the high rates of depressive symptoms among low-income, minority HIV-infected 
individuals, particularly those with co-occurring substance abuse (Berger-Greenstein et al., 
2007). Further, general distress and disruptions in mood can have a powerful impact on 
adherence regardless of diagnosis (Leserman, Ironson, O'Cleirigh, Fordiani, & Balbin, 
2008), suggesting that even individuals without clinical levels of depression may benefit 
from this approach.
Treatment Overview and Structure: The “Act Healthy” Group
The intervention described here integrates Life-Steps (Safren et al., 1999) and BA (Lejuez et 
al., 2001; 2011) for group delivery in a medical setting. Balancing the factors at this center 
described above, the group utilizes a flexible, modular format (e.g., CBT-AD; Safren et al., 
2009; 2012), with content repeated each week to account for nonsequential session 
attendance. The time spent on each module per session depends on patients’ presenting 
issues, similar to the flexible approach of other integrated CBT interventions for depression 
and adherence (i.e., CBT-AD; Safren, Gonzalez, & Soroudi, 2007; Safren et al., 2009; 
2012). This modular approach has been demonstrated to be a useful format to accommodate 
complex patient populations and stems from qualitative work suggesting the need for 
flexibility of interventions when working with HIV-infected individuals with multiple 
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comorbidities (Berg, Raminani, Greer, Harwood, & Safren, 2008; Soroudi et al., 2008). The 
treatment structure also includes a strong emphasis on peer contribution to lead review of 
previous sessions and to work collaboratively with others throughout treatment.
As part of the need to address variations in attendance, each and every session includes: (a) a 
discussion of medication adherence and skills within Life-Steps; (b) a review of the basic 
BA treatment rationale (see Figure 1 and description below), highlighting how disruptions in 
regular, meaningful, and enjoyable activities can contribute to worsening mood and 
medication nonadherence; and (c) activity monitoring, selection, and scheduling following 
from a goals-based assessment. These three main components are described in more detail 
below.
Life-Steps Module—As described previously, Life-Steps (Safren et al., 1999) is a brief, 
evidence-based intervention to improve HIV medication adherence that integrates 
informational, problem-solving, and cognitive behavioral techniques through 11 “steps” 
(e.g., psychoeducation, attending appointments, obtaining medications, communicating with 
providers, coping with side effects, formulating a daily medication schedule, storing 
medications, utilizing cue-control strategies for pill-taking, responding to slips, etc.). For 
each step, barriers and solutions are identified, along with a plan for implementing a 
solution. In the Act Healthy group, each step is briefly described every session, and patients 
decide as a group on one to two steps to discuss each week. Patients who attended 
previously have the opportunity to lead the Life-Steps review with assistance from the 
therapist. Problem-solving solutions and plans for implementing solutions are typically 
facilitated by the therapist with peer input.
BA Modules—BA techniques utilized in the Act Healthy group are derived from the most 
straightforward and brief version of BA (i.e., Lejuez et al., 2001; 2011) with adaptations 
previously tested for low-income individuals living with HIV/AIDS (Daughters et al., 2010). 
In the Act Healthy group, there are two main BA treatment modules: (a) the BA treatment 
rationale/psychoeducation; and (b) activity monitoring, selection, and scheduling.
BA treatment rationale: The BA treatment rationale is typically the first module covered in 
each session. Specifically, the links between negative feelings/emotions, urges, and negative 
behavior patterns are illustrated, along with ways to break this cycle with rewarding, 
enjoyable, and meaningful behavior. Next, the positive feelings that come along with this 
behavior change are highlighted, and it is illustrated how these feelings often increase the 
likelihood of continued engagement in positive behavior. See Figure 1 for an example 
depiction of the BA treatment rationale. The therapist typically leads the rationale in the 
initial sessions with active participation and engagement from patients when eliciting 
examples. After the first one to two sessions, patients are asked to volunteer to lead the 
treatment rationale with input from the therapist and other patients. Patients typically rotate 
to lead the cycle each week. This exercise transitions nicely into the next BA module—
activity monitoring, selection, and scheduling—in that the “positive” cycle elicits examples 
of positive behaviors that can be scheduled into one’s week.
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Activity monitoring, selection, and scheduling: In this module, attention turns to daily 
monitoring of activities and associated importance and enjoyment ratings, identifying 
values/goals across numerous areas of one’s life, generating measurable, observable 
activities that may reflect living a life according to these values/working towards these 
goals, and scheduling these activities into one’s day and week at concrete times. The activity 
monitoring and scheduling procedures are derived from Lejuez et al. (2011), which 
developed a more simplified approach to monitoring and scheduling activities using a single 
form (see Figure 2). This form is introduced as a monitoring form to be completed 
throughout the week (one per day), with specific activities scheduled throughout the week. 
Patients are instructed to indicate (by checking off “yes” or “no”) whether they were able to 
complete the scheduled activities. Scheduled activities are derived from a goals/values-based 
assessment across five life area domains (relationships, education/career, daily 
responsibilities, mind/body/spirituality, and interests/recreation; see Figure 3). Specifically, 
patients are asked to think about what is important to them in each of these five domains, 
and what types of activities would align with these goals/values. Patients are encouraged to 
select activities that are concrete and specific that they can schedule into their week. A 
problem-solving based approach is incorporated into the activity selection and scheduling 
exercise; activities are broken down into small, manageable steps before they are 
incorporated into one’s schedule. The goal selection process is patient-driven, and goals 
within each life area may not be measurable or achievable. However, the activities within 
each goal are meant to be objective and measurable. It is with activity selection that the 
therapist may be more likely to provide guidance in helping identify or select activities that 
are concrete, measurable, and that can then be assigned to schedule into one’s day or week. 
The life areas assessment is both introduced and reviewed in each session. Patients who 
have attended previously build upon previous weeks’ life area goals and activities, either 
selecting new life areas to focus on or adding to existing life area goals. Patients are 
encouraged to bring these forms back with them the next time they attend the session. Blank 
forms are also available in session for new patients and patients who do not bring their 
forms back to session.
Participants and Procedure
In total, 13 patients participated in the group over an 8-week period. Patients were 92.3% 
African American (n = 12), 46.2% female (n = 6), and mean age was 50.75 (SD = 9.88). 
Patients attended a mean of 3.46 sessions (range 1–8). There was a mean of 4.85 patients per 
group session (range 2–9). The group was delivered weekly for 8 weeks by a predoctoral 
graduate student in clinical psychology with previous training and 4 years of experience 
providing Life-Steps and BA, but no prior training in implementing a nonsequential 
treatment protocol. Treatment sessions lasted approximately 1 hour.
Participation in all aspects of this study was entirely voluntary, including treatment, exit 
interviews, and brief outcome assessments. Patients at this center were told by center staff 
that there was a weekly group available to them that would focus on improving their mood 
and ability to take their medications, ways to improve “healthy living” and reduce barriers to 
medication use, and that there would also be opportunities to provide feedback on their 
experiences in the group and participate in brief research assessments. They were also told 
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that they could participate in the treatment group regardless of their interest in participating 
in the research assessments or exit interviews. The center implements guidelines for all 
groups run at the center that were also in place for this treatment group; for instance, patients 
could not attend if they presented drunk or high. Patients were also required to meet with a 
psychiatrist or primary care provider (PCP) for medication evaluation/management at least 
two times per year, and if clinical staff believed patients’ current symptoms were too severe 
or may be disruptive to group members, they were required to attend the medication 
appointment prior to entry. There were no incentives given for participation in the research 
aspect of this group intervention.
Assessments
Assessment measures were administered at Week One (prior to the start of the first session) 
and at Week Eight (after the eighth session) and included a brief assessment of mental and 
physical health-related functioning, clinician-related depressive symptoms, and medication 
adherence. Mental and physical health-related functioning were assessed using the SF-12 
(Ware, Kosinski, & Keller, 1996). SF-12 scores range from 0–100 with a mean of 50 in the 
general population and higher scores reflecting better functioning. Two summary scores are 
calculated using the SF-12: a physical health composite score (PCS) and a mental health 
composite score (MCS). Clinician-related depressive symptoms were assessed using the 
Hamilton 7-item Rating Scale for Depression (HAMD-7; McIntyre et al., 2005). For the 
HAMD-7, scores range from zero to 26, and a score greater than 3 indicates clinically 
significant depressive symptoms. Medication adherence was assessed using a visual 
analogue scale of % medications taken in the past month from 0 to 100% adherence 
(Giordano, Guzman, Clark, Charlebois, & Bangsberg, 2004) and self-reported frequency of 
doses missed across a range of common reasons for nonadherence using a section of the 
AIDS Clinical Trials Group (ACTG) questionnaire (Chesney et al., 2000). In this section of 
the ACTG questionnaire, respondents are presented a list of 14 reasons why people may 
ever miss taking their medications (e.g., being away from home, busy with other things, 
simply forgot) and asked “how often have you missed taking your medications because you 
…” for each reason. Participants rate responses on a 4-point scale (never, rarely, sometimes, 
often) to indicate the frequency of nonadherence due to each of the 14 reasons. Responses 
are summed, with higher scores indicating greater frequency of reasons endorsed for 
nonadherence (scores range from zero to 42). We also examined the reasons each patient 
endorsed to provide richer information on individual barriers to adherence.
Research assessments took approximately 15 minutes and were conducted by a 
postbaccalaureate research assistant. The assessments were conducted separately from the 
clinical services provided, and participating in research was not required to attend the group. 
If patients were interested in participating in the assessments and exit interviews following 
treatment, all study procedures were described in depth and potential participants were 
provided written informed consent. Informed consent, exit interviews, and assessments were 
conducted in a private room at the center. All procedures were approved by the University 
IRB and approved by the program director and director of research at the host community 
health center. Four individuals participated in the research protocol (both research 
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assessments and follow-up exit interviews). Exit interviews lasted approximately 15 minutes 
(see Table 1 for a list of exit interview questions).
Case Examples
The following section provides case material to give interested clinicians a clearer sense of 
how these techniques may be implemented in the flexible, group format. First, an example 
group session is provided to depict more clearly the implementation of this approach. Next, 
case examples are presented of two individuals who attended the group and participated in 
assessments and exit interviews. Case illustrations are provided to illustrate how the 
treatment, although delivered in a group format, was individualized based on distinct 
medical and psychological patient needs. The two cases profiled were representative of the 
13 total group members. Their relatively high levels of self-reported adherence were in line 
with the high adherence of other group members. Although patients had different medical 
and psychiatric comorbidities, these cases are representative of the other members of the 
group who also had multiple medical and psychiatric comorbidities. Case descriptions are 
deidentified to preserve patient confidentiality.
“Group Session” Case Study
Although a “case study” often refers to profiling an individual patient in an intervention, a 
“group session” case example is presented here to provide a clearer depiction of this group 
in practice. Given the nonsequential format of this intervention, it is not a specific session 
“number” per se; the profiled session below was the fourth group session administered at 
this center. Although this is the “fourth” session, the content is representative of other 
sessions delivered given that there is not a sequential structure.
At this session, six patients were in attendance. Three had attended the group the previous 
week, one had attended 2 weeks prior, and two had not previously attended. The group 
began with the BA treatment rationale module. In this session, it was co-led by the therapist 
and one patient who had attended the previous week. The treatment rationale was depicted 
visually on a white board (see Figure 1 for another example), and patients discussed themes 
of sadness, frustration, loneliness, and numbness leading to urges to avoid friends and 
family, skip medications and appointments, smoke cigarettes, and “just give up.” They 
described often not being able to resist these urges—a point that was shared and resonated 
among group members— and then discussed strategies that had helped them in the past 
resist these urges.
The patient co-leading the module illustrated where to “break the cycle” (see Figure 1) with 
more meaningful, enjoyable, and rewarding activities, and fellow patients provided 
examples of positive activities, such as calling a friend, seeing a family member (particularly 
grandchildren), doing something artistic, getting outside, performing light exercise, dancing, 
and listening to music. Patients reported that although they could often identify these 
activities and knew that they may relieve some negative feelings, it was difficult to initiate 
the positive activities when they felt this way. This became a discussion point in the group, 
along with a discussion of what types of feelings typically follow when patients are able to 
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engage in these activities. The dialogue between patients was thoughtful and engaging when 
reviewing the treatment rationale cycle, and this module lasted approximately 20 minutes.
Next, the session focused on the BA activity monitoring and scheduling module. New 
activity monitoring and scheduling forms (see Figure 2) were given to the two patients who 
had not previously attended. Of the three that had attended the group the previous week, two 
brought the monitoring/scheduling forms to session. Both had monitored approximately 
50% of activities and had checked off the activities they planned for themselves. These two 
patients presented to the group what they had completed, focusing mostly on how the 
scheduled activities went. The therapist praised the homework completion and reinforced 
their efforts. Both patients discussed barriers and how they felt after engaging in the 
activities. This review took approximately 10 minutes and was used as a guide for new 
patients on how to complete the forms for next week.
The focus then turned to a discussion of the goal/activity assessment form across five life 
areas (see Figure 3). Each patient identified one life area and then established goals within 
that life area. The goal selection process is patient-driven, and as such the therapist did not 
intervene much in this process. Former patients added to previously completed forms (or 
identified a new life area if they did not bring their forms). Next, patients selected activities 
within each goal, and the therapist first led a discussion of the distinction between goals and 
activities for new patients, highlighting in particular the importance of breaking down 
activities into small, manageable pieces that are objective and measurable to work toward a 
larger goal. Next, the group members worked in groups or pairs to select specific activities 
to schedule for homework, with the therapist consulting each subgroup to monitor their 
progress and provide suggestions to select activities that are concrete, measurable, and that 
can then be assigned to schedule into one’s day or week. This allowed the therapist to give 
specialized attention to new patients who needed more guidance and allowed returning 
patients to take the lead in their own activity scheduling. Once this was set, two activities 
from each goal were transferred to the activity scheduling forms, each with a specific date 
and time for completion. This component took approximately 15 minutes.
This session finished with the Life-Steps module (approximately 15 minutes). First, each 
step was listed on the white board (written by a group member who had attended 2 weeks 
prior with the aid of other patients), and two steps were selected by the group as the focus of 
the session (appointment attendance and provider communication). Patients had an open 
discussion of barriers to attending appointments and challenges in provider communication 
(i.e., discomfort with PCP, difficulty remembering questions). Structured problem-solving 
techniques were led by the therapist to address these issues in addition to recommendations 
provided by other group members. Appointments and medication times were also written 
into the activity scheduling homework forms for patients who had difficulties with these 
issues.
Although each group session differed somewhat in terms of time spent on each module or 
the specific themes or highlights addressed in each module (i.e., what types of activities or 
specific life areas in the BA module, what medication adherence-focused concerns in the 
Life-Steps module), a somewhat similar structure remained across sessions, and all content 
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was drawn from consistent modules across sessions. Additionally, some sessions began with 
Life-Steps as opposed to BA in order to balance any potential impact that order may have 
had on the amount of time spent on each module.
Case 1
Mike H. is an African American heterosexual man in his mid-50s who was infected with 
HIV in the late 1980s through injection drug use. At the time of treatment, he lived in urban 
low-income housing in an apartment with his brother. He had been receiving his outpatient 
medical care at the study site for 8 years and had a regular PCP at this site. In addition to 
HIV, Mike also had been diagnosed with hepatitis C, hypertension, and sleep apnea. Mike 
was not engaged in consistent psychiatric or psychological care and tended to address any 
psychiatric symptoms with his PCP. His medical record indicated previous diagnoses of 
bipolar disorder and schizophrenia (both diagnoses were first documented in his early 
thirties). Mike reported no current symptoms of mania or schizophrenia at entry into the 
group and could not recall the last time he experienced any of these symptoms. Mike’s 
antiretroviral therapy regimen included the drugs Isentress (one pill twice a day) and 
Truvada (one pill taken once a day). His first antiretroviral treatment began in the early 
1990s, and the current regimen was initiated in 2009.
Mike reported interest in participating in this group because he often felt down and had 
concerns that he was sleeping too much. In his first session, he stated he felt like he did not 
have many coping skills to improve his mood or take his medications on days he felt down. 
At the baseline assessment, Mike’s HAMD-7 score was 4, indicating clinically elevated 
depressive symptoms (scores range from zero to 26 and greater than 3 on the HAMD-7 
indicates clinically significant depressive symptoms). Although Mike reported 100% 
medication adherence in the past month on the visual analogue scale, he endorsed missing 
doses across a range of reasons (being away from home, being busy with other things, 
simply forgetting, wanting to avoid side effects, feeling sick or ill, and having problems 
taking pills at specified times), indicating there were barriers to adherence. His score on the 
ACTG frequency of reasons endorsed across reasons for nonadherence scale was a 25 at 
baseline (although no clinical ranges are available for this measure, scores range from zero 
to 42). Mike’s scores on the subscales of the SF-12 at baseline were 29.1 for the PCS and 
50.1 for the MCS, indicating worse physical health functioning as compared to the general 
population and average mental health functioning compared to the general population (a 
score of 50 on both subscales reflects the mean for the general population). Over the 8-week 
period, Mike attended five sessions, which was above the mean for the group (on average 
patients attended a mean of 3.46 sessions over the 8-week study period).
During the course of treatment, Mike showed a strong grasp of the treatment rationale and 
acknowledged the importance of positive daily activities in his life. Although Mike tended 
to be reticent during sessions, the therapist made sure to call on Mike when topics arose that 
were especially relevant to him (i.e., oversleeping, and how to address it) to maximize his 
participation. When called upon to contribute, he demonstrated a clear understanding of the 
negative and positive cycles depicted in the treatment rationale module. He also provided 
insightful comments to others when they reported negative feelings and urges—for instance, 
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pointing out that taking time to think about the specific negative consequences, such as jail 
time or health complications, was often an effective way to resist negative urges. One 
challenge was that Mike would be reluctant to endorse feelings of depression or sadness, yet 
he did identify with corresponding urges of “wanting to give up” and “trying to sleep all 
day.” Throughout his participation, the therapist was careful to utilize the expressions and 
descriptions of symptoms that were most in line with those Mike recognized and with which 
he identified.
Mike wanted to focus almost exclusively on the life area of education/career. Specifically, 
he wanted to obtain a full-time job working at a local pharmacy. He often found that in the 
past when he was working, he would have fewer days that he felt this desire to just “give 
up” and he could not sleep all day. He reported feeling happier during these periods, and he 
was also much more easily able to take his medications when he had a rigid routine. Given 
Mike’s strong desire to obtain employment, he prioritized this goal and breaking down this 
goal into manageable pieces consistently throughout treatment. Due to his high computer 
literacy skills, many of Mike’s scheduled activities outside of treatment involved 
designating time in his day to search for and apply to entry-level jobs on the Internet. During 
group, he broke down these activities into smaller pieces (i.e., how long to search for, what 
websites to use, how many to apply to each day, gathering necessary materials for the 
application). He also prioritized creating a resume, which involved numerous specific 
activities (e.g., asking former coworkers for examples and asking a counselor at the center, 
with whom he had a good relationship, to review his first draft). Additionally, he wanted to 
prepare for interviews, and one activity he identified was to ask this same counselor at the 
center if he would do a mock interview with him. Although staff are not typically available 
to patients for job-related support, Mike skillfully asked this counselor for specific feedback 
and support, and the staff member agreed. By the end of the treatment period, Mike had 
secured a part-time temporary position at a local pharmacy for 1 month. At the 8-week 
assessment, he reported that he was continuing to look for full-time employment at 
pharmacies and grocery stores using the same strategies he focused on in BA.
Mike’s adherence-related goals were very closely linked with obtaining employment. Mike 
reported rarely missing medications during previous periods of employment given the 
regularity of the routine, more regular sleep schedule, and his overall improved mood and 
“purpose.” Thus, he felt that prioritizing obtaining employment would also enable improved 
adherence. One challenge with Mike was that he initially felt that finding a job was the only 
thing he could do to improve his adherence. However, the therapist encouraged him to set an 
additional adherence-specific goal prior to obtaining employment, which was to increase the 
use of alarms to prevent times in which oversleeping interfered with his morning medication 
schedule. By the end of the 8-week period, he had successfully borrowed an extra backup 
alarm from his brother and had implemented regular alarm use to wake up prior to his 
morning medication time.
Mike’s homework completion was among the highest of the group members. He brought his 
activity monitoring and scheduling homework forms back to each of four later sessions he 
attended. Mike completed all of the activities he had scheduled during group, and on two 
occasions he added four additional activities. He preferred to focus on activity scheduling as 
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opposed to monitoring, and this became even more of a priority once he started work, as he 
did not want to bring his forms to his job. Once he started working, we also discussed ways 
in which he could continue the activity scheduling exercises without the use of forms (i.e., 
putting scheduled activities into his personal calendar). He discussed how having the same 
activities scheduled each week helped with regularity of routine, which was important to 
him for his adherence, as well as for remembering the scheduled activities without the use of 
paper forms.
From the baseline assessment to Week Eight, Mike’s HAMD score dropped from above the 
clinical threshold initially (score of 4) to zero, indicating no depressive symptoms. His 
reported adherence in the past month on a visual analogue scale remained steady at 100%. 
Following treatment, he reported a lower frequency of missing doses and fewer reasons for 
missed doses (wanting to avoid side effects, feeling like the drug was toxic/harmful, feeling 
sick or ill, or feeling good). The total frequency of his reasons endorsed for nonadherence of 
25 at baseline decreased to 9 following treatment. His SF-12 PCS score rose to 42.7 at Week 
Eight, which reflects physical health functioning below the mean in the general population, 
and his MCS score remained stable (51.1) at the population mean.
Case 2
Tawanda M. was an African American woman in her mid-30s who had more recently 
initiated care at the center (in the past year). She was diagnosed with HIV in the mid-1990s 
when she became pregnant. She believes she was infected with HIV from a casual male 
partner. At the time of treatment, Tawanda lived with her husband of 10 years and her 17-
year-old daughter. Five years prior, Tawanda was diagnosed with bipolar disorder after 
suffering a “nervous breakdown” when her mother died, which was also documented in her 
medical record. Tawanda’s medical history included genital herpes (diagnosed in early 
2000s), a hernia, hypothyroidism, and high cholesterol. Tawanda’s antiretroviral therapy 
regimen included one pill of Prezista, Epzicom, and Norvir once a day and one pill of 
Isentress twice a day, which was a regimen she had started 2 years prior. Tawanda initiated 
antiretroviral therapy in the late 90s.
Tawanda had severe depressive symptoms at baseline (HAMD score of 14; scores range 
from zero to 26 with a score above 3 indicating clinically significant depressive symptoms). 
She reported no suicidal ideation at baseline. On a self-reported visual analogue scale of 
adherence, Tawanda indicated 97% adherence over the month before baseline. She reported 
numerous reasons for missing doses, including being away from home, simply forgetting, 
having too many pills to take, wanting to avoid side effects, having a change in daily 
routine, feeling like the drug was toxic/harmful, feeling depressed/overwhelmed, running 
out of pills, and feeling good. The frequency of missing doses across these reasons was a 12 
at baseline (scores range from zero to 42). On the SF-12, her baseline PCS score was 40.9 
and 32.8 for the MCS, indicating physical and mental health functioning below the mean of 
50 in the general population on both physical and mental health functioning.
Tawanda elected to focus on the life areas of education/career and mind, body, and 
spirituality. More specifically, Towanda focused on the goals of finding a job and getting 
closer to God through involvement with her church. Activities related to finding a job 
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centered around using a computer available at the center during times she came in for her 
appointments to search for jobs, asking a nurse social worker at the center to talk with her 
for 15 minutes after one of her appointments about guidance in the job application process, 
and to stop by local stores and movie theaters on her way home from the center to inquire 
about potential employment opportunities. Regarding her spirituality goal, Tawanda planned 
to go to church each Sunday with her daughter—also a chance to spend quality time with 
her—as well as get involved in the biweekly events the church put on that included 
volunteering, cleaning the church, and choir-related activities. Tawanda identified these 
activities as a way to get closer to God and connect with others who also value the church in 
their lives. In the group setting together with the therapist and other peers, she broke down 
these activities into the smallest, most specific possible steps to then schedule into her day. 
She also discussed potential barriers in this process; for instance, she had some concerns 
regarding others knowing her HIV status, which she described as a barrier to engaging in 
these activities.
Towards the end of eight weeks, Tawanda had asked to meet with the social worker at the 
Center, met with her for 15 minutes on two occasions, spent two hours using the Center 
computer to apply for jobs, stopped by a local movie theater on her way home, and applied 
to two jobs (at a movie theater and local retail store), although she had not received a 
response from either. Additionally, she attended church regularly on Sundays with her 
daughter and attended two church-sponsored events (volunteering and choir). She continued 
to report some concern regarding others knowing her HIV status at the church, but that she 
attended regardless and that it was easier on Sundays with her daughter. She described the 
accountability of the treatment groups as a motivating factor to follow through with 
scheduled activities.
In the Life-Steps module, she discussed her frequent struggles with transportation to 
appointments. She identified numerous strategies and activities that may reduce 
transportation barriers to appointments (i.e., speaking with her husband about her 
transportation needs, scheduling appointments back to back when possible). As this was a 
recurring challenge for Tawanda, the therapist asked other group members if they had ideas 
of suggestions or resources for her. This strategy proved very successful, as a fellow group 
member pointed Tawanda toward a resource that pays the cost of public transportation to 
appointments—a resource that she was successfully utilizing by the end of treatment. 
Another key focus for Tawanda during the Life-Steps module was what her medications 
reminded her of; she indicated that medication acted as a reminder that she infected her 
husband with HIV. The Life-Steps strategies that focus on changing the meaning of 
medications were very relevant to Tawanda—specifically to change the meaning of the 
medications to be a reminder that the pills are lifegiving and a sign she is taking care of her 
health. Although Tawanda reported understanding this concept, it was unclear whether this 
shift in her views of her medications was achieved by the final week of treatment.
Tawanda’s BA goals and medication adherence strategies in Life-Steps were closely 
connected. Specifically, Tawanda had not disclosed her HIV status to anyone outside her 
family. Regarding female relationships in particular, she felt disconnected from her close 
female friends and reported feeling overly reliant on her 17-year-old daughter for emotional 
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support. During treatment, her daughter was in the process of applying to college, and she 
experienced significant anxiety associated with her daughter leaving home. Additional BA 
goals focused on expanding her network of female friends as well as doing more social 
activities outside the home through her church. Related to medication adherence 
specifically, Tawanda would often hide her medications when she wanted to have friends 
over, which would contribute to nonadherence. Alternatively, she would also have periods 
of not inviting friends to her home, which was a valued activity for her. In both the Life-
Steps and BA modules, balancing these two priorities was discussed; although she was not 
ready to disclose her status to her friends, other ways to maintain social contact and continue 
to prioritize adherence-related goals were discussed. Given that Tawanda’s fears about 
disclosing her status to others were such a pervasive concern, the therapist invited the entire 
group to comment briefly on any of their experiences related to disclosure (or lack thereof) 
of their HIV status. The short anecdotes two group members shared as part of this discussion 
appeared as helpful to them to share as they were for Tawanda to hear, and served to build 
rapport among the group members and the therapist.
Completing the monitoring and scheduling forms in between sessions was challenging for 
Tawanda. Specifically, she often forgot to record her activities on the homework forms and 
to check off scheduled activities to indicate she completed them. She attended five of the 
eight treatment sessions and brought her forms back to group one out of four possible 
sessions. Tawanda indicated she struggled to keep track of her forms after she went home 
but decided to keep them in a prominent place (the top of her dresser). This strategy worked 
for her for the last session she attended. She also reported more heavily relying on her own 
personal calendar.
After 8 weeks, Tawanda demonstrated clinically significant reductions in depression; her 
HAMD scores reduced from 14 at baseline to two, which is below the cutoff for clinically 
significant depressive symptoms. On the self-reported visual analogue scale of adherence, 
she increased from 97% to 100% adherence in the final 4 weeks of treatment. At 8 weeks, 
she reported similar reasons for nonadherence prior to treatment, and the frequency these 
reasons interfered with her medication adherence also remained stable (score of 13). Her 
physical health and mental-health-related functioning improved slightly over 8 weeks. Her 
PCS score increased from 40.9 to 49.7, and her MCS score increased from 32.8 to 39.5, both 




Examining outcomes over 8 weeks (n = 4), there were clinically significant reductions in 
HAMD scores from baseline from above the clinical cutoff of three (mean = 5.00; S.D. = 
6.22) to below this clinical cut-off at Week Eight (mean = .75; S.D. = .96). There were also 
improvements in overall physical health-related functioning from baseline (mean = 41.63; 
SD = 11.32) to Week Eight (mean = 48.38; SD = 5.15) and improvements in mental-health-
related functioning from baseline (mean = 46.28; SD = 11.99) to Week Eight (mean = 49.98; 
SD = 8.32), although both the mean baseline and Week Eight scores remained below the 
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mean in the general population (50 for both the PCS and MCS). Regarding adherence, there 
were slight increases in adherence on a visual analogue scale from baseline (mean = 99.0; 
SD = 1.73) to Week 8 (mean = 100.0; SD = 0.0), and lower frequency of reasons endorsed 
for nonadherence from baseline (mean = 12.25; SD = 9.11) to Week 8 (mean = 9.5; SD = 
6.95). Although clinical ranges are not available for this section of the ACTG assessing 
frequency of reasons endorsed for nonadherence, total scores range from zero to 42.
Exit Interview Feedback on the Intervention
Exit interviews were conducted after 8 weeks. Patients were asked to provide candid 
feedback about what aspects of group they found effective and recommendations for future 
modifications. Exit interview questions and synthesis of patient responses (n = 4) are 
included in Table 1. A few main themes emerged from participant feedback: an 
understanding of the treatment rationale, a sense of accomplishment from activity 
scheduling, an appreciation of being able to lead components of the group, and difficulties 
with homework completion.
Patients’ summaries of the group reflected a strong grasp of its content; patients described 
planning positive activities as a main focus of the group and gave concrete examples of 
goals they accomplished through completion of smaller, goal-directed activities. These 
included activities such as going to sleep at a specific time, taking walks for exercise every 
day, cleaning the kitchen, job application–related activities, and talking to doctors about side 
effects of HIV medications. Patients cited repeated review of the treatment rationale as a 
strength of the treatment; they felt it gave them an outlet to not just describe negative 
feelings, but also to get feedback on potential positive outlets from other group members and 
the therapist. Patients also indicated it allowed them to show what content they learned and 
recalled from previous sessions. The collaborative nature of the group was also referenced 
throughout interviews. For example, patients who missed a group one week reported they 
never felt lost or behind when they came back to group because their peers filled them in 
and led a review of previous sessions’ content.
Completing homework was something most patients felt was challenging, whether it was 
forgetting to fill out the forms, losing them at home, or forgetting to bring them back to the 
center. There were homework challenges that seemed unique to each patient, and several 
suggestions were provided that may be useful to adapt homework in the future. For instance, 
one patient recommended writing activities for each day on colorful sticky-notes (i.e., for 
the fridge). Overall, the interview feedback was positive, with all patients stating that they 
would recommend the group to others. This feedback will also help to inform future 
adaptations of the approach. See Table 1 for a list of exit interview questions and a 
compilation of example participant responses.
Discussion
Implementation Tips and Challenges
There were numerous challenges faced and lessons learned in the process of implementing 
BA and Life-Steps in a modular, nonsequential group format in an HIV community health 
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center. A primary challenge was how to implement techniques effectively in the 
nonsequential format, balancing the need to engage patients who had attended the previous 
week with the needs of patients attending for the first time. One strategy that became 
particularly important to engage patients with regular past attendance was to utilize peer-led 
strategies. In particular, as done in previous BA studies (Daughters et al., 2008; Magidson et 
al., 2011), weekly patients volunteered to lead the treatment rationale cycle on a white board 
in front of the group after previous weeks’ attendance, which was facilitated by therapist and 
other patient input. Peers also offered support to other group members when filling out 
forms, brainstorming ideas for activities, and discussing obstacles to medication adherence. 
Individuals who had attended prior sessions could continue to build upon the life areas goals 
assessment, adding new goals across life areas and/or additional activities for existing life 
area goals; this allowed for all group members to be working on the same forms even if at 
different stages of completion. Additionally, regarding therapist training in this approach, 
future efforts to train clinicians in this type of protocol may consider content focused on 
adjusting to the nonsequential format.
Homework is a primary component of traditional CBT interventions delivered in a mental 
health setting; yet, assigning and reviewing written homework forms became less central in 
this nonsequential format. Many patients scheduled activities in other formats (using 
personalized calendars, notes at home, or without writing), and all formats for homework 
completion were reinforced regardless of format or whether the patient was planning to 
attend the following week. In BA protocols specifically, an in-depth review of activity 
monitoring is central to the therapeutic process; however, this became less feasible in a 
group format, particularly when multiple weeks had passed and the focus became more 
about training patients to be their own therapists to identify patterns in their activities and 
mood. Reviewing activity scheduling/completion during session was more feasible than a 
detailed review of activity monitoring. Patients were encouraged to find accountability from 
others in their environment for activity scheduling and completion when they could not 
attend the following week. Although other formats and techniques were utilized, assigning 
and reviewing homework in this context was perhaps the most challenging aspect of 
delivering the intervention.
Based on these experiences and feedback from patients, we believe the amount and type of 
homework should take into consideration the frequency and quality of clinical contact with 
patients, and clinicians should be prepared to adapt the homework format and delivery based 
upon these characteristics. For instance, some patients had multiple appointments per week, 
whereas others only came to the center once per month or less frequently. Thus, from our 
experience delivering the intervention, we found that the amount of activities to be 
scheduled in the BA protocol may change based on the frequency of clinical contact. More 
specifically, we found that it would not be feasible to generate a month’s worth of BA 
activities at one monthly appointment. In this case, the therapist and patient may consider 
generating a new activity that will likely happen each week to be scheduled on a specific 
day of the week (e.g., “take my grandchild to the park every Sunday afternoon.”) On the 
other hand, patients who have more frequent group attendance (e.g., once per week), could 
schedule activities for each day until their next group session. For patients who struggle a lot 
with homework, the therapist may consider just assigning one activity per week for later that 
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same day of the group session. The essence of these recommendations is less that homework 
should be optional or only happen for certain sessions, but rather the amount/difficulty/
frequency of the activities for homework should take into account how long it will be until 
the patient is likely able to attend group again.
In addition to modifications based upon schedule, there was also some feedback that the 
homework “wasn’t fun.” Some recommendations to make the homework forms more 
appealing include making them into a more colorful booklet, planner, or peel-away day 
calendar. Another option is to make the homework booklet small and easy to carry around at 
all times (i.e., similar to the pocket BA manuals utilized in Daughters et al., 2008, and 
Magidson et al., 2011). Another option to tailor homework to patient preferences is to ask 
patients in what ways they keep themselves organized currently, and attempt to integrate the 
format of the homework with what already works (e.g., notes on the refrigerator, Post-it 
notes, reminder stickers, or using a notes/calendar function on a cell phone). Additionally, 
although it is ideal for patients to be tracking activity completion and/or adherence in some 
way, if they prefer to verbally discuss activity completion without recording it (e.g., due to 
literacy issues or disabilities), this would also be preferable to not assigning homework.
Another key challenge that emerged was that patients were not presenting necessarily with a 
specific “diagnosis” or “presenting problem.” Patients were not screened into the group 
based on a formal depression or substance use disorder diagnosis; rather, the group was open 
to all patients interested (although there were policies in place at the center to ensure that 
patients who would be too disruptive could not be included—for instance, patients who 
presented drunk or high or were not stabilized on psychotropic medication/in psychiatric 
care through a specialist or a PCP could not participate). Patients were told the group would 
focus on various aspects of “healthy living,” including mood, healthy behaviors, and 
adhering to medication. Although this was particularly appealing to community health 
center staff wanting to maximize mental health resources for treatment-seeking patients, the 
heterogeneity of the group also presented challenges when prioritizing patient needs; for 
instance, the group often included patients with a wide range of ages, years living with HIV/
AIDS, depression severity, and substance use issues, which influenced what content was 
most heavily focused upon in BA and Life-Steps. Each of the treatment components could 
easily be individualized and adapted to specific patient needs even in a group format, which 
has been a noted advantage of BA protocols (i.e., that they can be easily individualized to 
patient needs and priorities; Lejuez et al., 2011; Sturmey, 2009). For instance, specific 
adherence difficulties and strategies were individualized to each patient, as were the targeted 
goal-driven activities patients selected to implement. Given the flexible, modular format, we 
could also vary the specific time spent on each component based on patients’ needs and 
presenting issues on that day, but all components were covered in all sessions. Additionally, 
in line with this issue, not all patients identified with feeling “depressed” or “anxious.” The 
therapist was careful to use the words patients used to describe symptoms, normalize 
feelings of being down or depressed, and discuss how even when not “diagnosed” with 
depression, these tendencies can affect our ability to take our medications and engage in 
enjoyable activities. As depicted in the BA treatment rationale (Figure 1), the term “negative 
feelings” was used, as patients identified with this terminology.
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Another significant challenge in this experience was how to accommodate various 
disabilities of patients who attended the group, including learning disabilities and other 
handicaps, which are often more common among individuals living with HIV/AIDS. For 
instance, one patient who attended regularly was visually impaired. The visual nature of the 
treatment rationale cycle and use of written forms were not feasible for this patient. 
However, one of her goals was to work on her handwriting, so she used the forms as a way 
to practice that goal. Other patients also helped her with completing her forms and tried to 
verbally summarize session concepts when possible to avoid overreliance on visual 
depictions.
Another challenge that presented in this group was how to engage patients, many of whom 
had been infected with HIV/AIDS for over 10 years, on Life-Steps material. Even in the 
presence of overall high levels of adherence, revisiting this material can be helpful, as 
previous research has shown that individuals may be likely to demonstrate poor adherence 
even after many years of managing HIV (Howard et al., 2002). Further, even individuals in 
this study who reported 100% adherence continued to report barriers to adherence, 
suggesting there is still room to address specific reasons or obstacles to adherence. Further, 
inaccurate beliefs may remain, even among those with high self-reported adherence. For 
instance, in this group, overall rates of adherence were high, but there were often gaps in 
their knowledge; they could identify that a high CD4 count and low viral load were “good,” 
but few of the group members knew or could recall what CD4 counts or viral loads meant 
prior to attending the Life-Steps module.
In examining patient feedback, individual patients appeared to give contradictory feedback 
on Life-Steps material, with one patient saying he was “sick of hearing about medicine” and 
later requesting “more information about side effects of HIV meds.” Overall, feedback on 
Life-Steps seemed to suggest that patients were “tired” of hearing about the importance of 
taking HIV medication and attending medical appointments, as this information had been 
presented to them in the same way for years. Many patients indicated that the adherence-
related material they had received in the past was not helpful in increasing their level of 
adherence, and patients thought initially that this information would be the same. However, 
patients reported that they liked that the medication-related information in the Life-Steps 
module was discussed in the context of other activities and their mood and “not just the 
facts.” Many patients also discussed wanting more of a say in dictating what types of 
questions and information would be most useful to them. For example, many patients had 
questions about side effects of specific antiretroviral therapy drugs, new regimens available, 
how adherence to antiretroviral therapy could affect HIV transmission, and how medications 
work to stop replication of the virus. Despite years and even decades of contact with medical 
providers, group members expressed a feeling they were always “following doctors’ orders” 
without understanding the rationale behind those orders or the implications of them. This 
feedback was addressed using the flexible nature of the Life-Steps approach; the therapist 
made every effort to focus on particular “steps” that were most pertinent to the patients in 
attendance.
Although adaptations stemmed from setting-specific staff feedback and treatment needs, 
similar changes may be applicable to other medical settings without existing implementation 
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of CBT. Settings with fewer resources available—for instance, without computers available 
to patients or on-site mental health staff who were available for ongoing support—may 
require even more attention in BA to assisting patients in creatively exploring what 
resources are indeed available at low cost in their community. This may in fact be more 
challenging when not on-site or immediately available, yet may provide even more 
opportunities for building these skills, which are the core of the BA approach. Other ideas 
for adaptation in low-resource community health settings may include the therapist focusing 
on identifying activities that may put patients in touch with external resources and available 
support systems, for example, how to become connected with a case manager or mental 
health worker. Those in substance abuse recovery may have a sponsor and sober network 
they can access. Additionally, as we learned throughout the implementation of this group, 
peers can be an incredibly helpful resource, and in this case, peers may also offer ideas for 
generating activities to determine what resources may be available. One example in the 
current study occurred when a patient said she struggled to afford transportation to 
appointments; a fellow group member pointed her to a program that covered the cost of 
public transportation for appointments, and by the end of the treatment she was successfully 
utilizing that resource. A similar idea may be to develop a list of low-cost activities and 
resources based on ideas generated throughout treatment, which could later serve as a 
reference to future groups being run at a given center. In sum, at low-resource settings, it is 
not necessary in this approach that patients find resources at the center where the treatment 
is being delivered. In fact, it may be even more helpful for patients long-term if they have to 
learn how to skillfully identify resources externally in order to make these changes more 
lasting in their environment. This may also further strengthen the key focus of BA—learning 
this skill of how to identify and pursue goal-driven activities.
Finally, regarding attendance, it is important to note that participants on average attended 
less than half of the eight sessions (i.e., a mean of 3.46 sessions). It is unclear at this stage of 
research whether nonattendance may be an issue for this program. There is empirical 
support for a single session of Life-Steps (Safren et al., 2001) and BA (Gawrysiak, Nicholas, 
& Hopko, 2009), which would suggest that even fewer than half of the sessions would be 
beneficial, particularly given that content is repeated weekly; however, larger trials 
evaluating this group will be necessary to determine the optimal number of sessions 
necessary for this approach to be effective. Further, in the current study, there were no 
efforts to promote or incentivize attendance: we were interested in rates of attendance 
without these efforts. However, it will be important to investigate strategies to promote 
attendance if nonattendance is an issue in future trials.
Limitations
In interpreting the preliminary outcomes of the patients assessed in this study, key 
limitations to consider may be the questionable representativeness of the research protocol 
sample. Only four individuals out of 13 total who attended the group completed research 
assessments; research involvement was not required for clinical participation, and thus, it 
may be a biased sample that elected to participate in research. Future plans to conduct a 
randomized trial to test the efficacy of this intervention will require higher rates of research 
participation. Similarly, it is also important to note that the 2 case studies presented may not 
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be representative of the 13 total group members, as these 2 patients had higher attendance 
than the mean for the sample.
Another limitation is that throughout the sample as well as in the individual cases, there 
were high rates of adherence at baseline. Thus, we cannot ascertain from this study how this 
treatment may affect individuals with low baseline adherence. Previous studies of Life-Steps 
have demonstrated significant improvements in adherence among individuals with low 
baseline adherence. In future trials (vs. clinical adaptation projects such as this study), it will 
be important to consider recruiting based upon adherence levels; however, given that this 
project was a clinical service and staff wanted to provide it to anyone interested, it was not a 
key focus here, but remains a point important to acknowledge as a limitation and key 
consideration for future work.
Additionally, given the high rates of self-reported adherence, we relied more on the 
assessment of the frequency of missed doses across a range of reasons for nonadherence 
when capturing the changes in adherence in this sample. Although querying for reasons for 
nonadherence has been suggested to be a strategy to minimize social desirability biases and 
other inaccuracies of self-reported adherence by not asking about missed doses directly 
(Simoni et al., 2006), there are limitations to this measure. It may be that some individuals 
perceive greater barriers to adherence and report nonadherence across a range of reasons, 
whereas other individuals may consistently miss more doses but for a single reason. In this 
case, the measurement of frequency of reasons endorsed for nonadherence may not 
accurately reflect number of missed doses. However, despite these potential limitations of 
using reasons endorsed for nonadherence as a proxy for adherence behavior, the measure 
does provide rich clinical information about barriers to adherence that is not captured by 
reporting on missed doses, which has the potential to provide useful clinical targets in future 
developments of this work.
Conclusions
This report represents initial efforts to implement an integrated BA and Life-Steps treatment 
to improve depression and medication adherence in an outpatient community health center 
for individuals living with HIV/AIDS. Specific adaptations were necessary for delivery in a 
community health center, including a flexible, modular group format that did not rely on 
weekly, sequential session attendance. This report represents the first effort to implement 
Life-Steps in a group setting in conjunction with a brief BA protocol. There were numerous 
lessons learned, including how to address homework assignments and review without 
sequential session attendance, how to tailor medication adherence content most effectively, 
and how to utilize peer-led strategies to balance frequent attendees’ engagement with new 
patients’ needs. Preliminary evidence suggests feasibility of the approach and positive 
effects on mental and physical health functioning, depressive symptoms, and barriers to 
medication adherence over an 8-week period. This is a first step in disseminating integrated, 
evidence-based techniques for depression and adherence into a community health center for 
a hard-to-reach and difficult-to-treat population. Implementing interventions tested and 
designed for individual treatment in a mental health setting for group delivery in a medical 
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setting is a struggle across types of disorders and interventions; it is our hope that the 
adaptation process and format depicted here may guide similar efforts in the future.
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• Implemented behavioral activation and Life-Steps in an HIV community health 
center
• Designed a modular, group format that did not rely on sequential session 
attendance
• Used peer-led and therapist-facilitated strategies to balance treatment needs of 
previous and new patients
• Learned that homework assignment and review should be tailored based on 
attendance
• Provide case examples and materials to depict how to implement techniques
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Depiction of BA treatment rationale reviewed at the start of each session. This was based 
upon the BA treatment rationale depicted in Act Healthy (Daughters et al., 2010). 
Specifically, this figure is introduced to patients step-by-step illustrating how the treatment 
is meant to break the negative cycle (i.e., where the “x” is) and start a new more positive 
cycle.
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Activity monitoring and scheduling forms introduced and reviewed at each session. This 
form was adapted from Lejuez et al. (2011).
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Life Areas, Goals, and Activities Inventory. Note that only one table per life area is depicted 
here due to space constraints; however, participants could work on more than one goal in 
each life area.
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Table 1
Compilation of exit interview questions and example participant responses.
Questions Participant Responses*
1. In your own words, what would you 
say was the purpose of the group?
The group helped me and motivated us to think ahead of time, as opposed to just saying, ‘OK, I woke 
up this morning. Now what?’ We went further into our thought pattern and said, ‘Hey, let’s plan for 
the next day.’ And it [the group] not only talked about your physical, but about your mental health, 
and accomplishments—what you want to do, and some life stressors. [We talked about] things you 
can do to take the stress off, and how to remember to take your medication.
2. Tell me something that you feel you 
will take away from the group.
I learned to be specific with what I plan. Even if I don’t do it, I have something planned each day. 
Positive things.
3. What were some goals that you set 
for yourself? What was your progress 
with those goals?
One thing I did was to go to bed later. I was going to bed too early and waking up in the middle of 
the night. That [change] has worked out great. I’m sleeping my eight hours and feel good in the 
morning. It also helped with my morning meds.
4. What, if anything, made it difficult 
to bring the homework forms back to 
group?
Because during the week you get caught up in your day, your family activities, and you forget. 
Maybe it’s my medication … it’s easy to forget those types of things and papers. For me, I don’t like 
to do a lot of homework. It wasn’t fun.
5. What changes would make it easier 
to bring the goal forms back with you?
Leave homework forms somewhere you are each day and can fill them out on a daily basis. The same 
place every day so it doesn’t get lost. Or, instead of doing logs, we could use stickies that you put on 
your refrigerator, and make the stickies colorful, too, so that they stand out.
6. Did you learn anything from the 
other group members?
They gave me ideas for my goals, like how to find a good case manager, and I got tips on how to 
make transportation to appointments easier.
7. What was the most helpful part of 
the group for you?
Probably I would say the [positive and negative] cycles. I still want to see if I can do them by myself. 
And talking about appointments and taking meds.
8. What was the least helpful part of 
the group for you?
The homework forms because they were hard to remember.
9. If you missed a week of the group, 
did you feel lost or behind when you 
came the next time?
We never got behind because there was always review. The other group members helped a lot, too. A 
few people really took the lead when they could be there the past couple weeks.
10. Would you recommend this group 
to other patients like you? Why or why 
not?
Yes, I’d really recommend it to someone who just got diagnosed, to learn about taking your 
medications. I wanted to get undetectable with my viral load and I accomplished that.
11. What would you change about the 
group?
Sometimes I don’t want to hear no more about this medicine! Most of us learned the hard way not to 
miss our meds. I think focusing on other medical stuff more besides taking meds.
Note.
*
A single participant’s response was included for each question. The feedback received in the exit interviews was quite uniform; we provided a 
single answer for each response to avoid redundancy.
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